NCT07531459Recruiting
Compilation and Preliminary Application of the Active Health Behavior Scale in Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 15 Apr 2026
Brief summary (registry, in English)
This study aims to develop the Active Health Behavior Scale for Type 2 Diabetes Mellitus (T2DM) patients and evaluate its psychometric properties, including internal consistency reliability, test-retest reliability, content validity, construct validity, and criterion-related validity. Additionally, this research will investigate the current status of active health behaviors among T2DM patients and employ latent profile analysis (LPA) to identify distinct behavioral subtypes. Furthermore, differences in demographic, clinical, and psychosocial determinants across the identified latent classes will be examined to inform tailored intervention strategies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 31 Mar 2026
- Start date
- 24 Dec 2025
- Primary completion date
- 20 Feb 2027
- Lead sponsor
- Yun Ye
- Diseases
- Type 2 diabetes
- NCT number
- NCT07531459
What you commit to
- Study type: Observational
- Planned participants: 600
- From 24 Dec 2025 to the primary completion date, 20 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with T2DM:
- Who have acute complications of T2DM or other serious life-threatening diseases that preclude cooperation with the study;
- Who have cognitive impairment or are unable to communicate in writing or verbally
- Healthcare workers:
Other
- Who do not have direct contact with patients;
- Who are currently undergoing standardized training or refresher programs.
Who the study is looking for
- Patients with T2DM
- Who have been diagnosed with T2DM and meet the diagnostic criteria defined by the Chinese Guideline for the Prevention and Treatment of Diabetes (2024 Edition);
- Aged ≥18 years;
- Who volunteer to participate in this study.
- Healthcare workers:
- Clinicians and nurses who have been engaged in medical care in the endocrine field for ≥5 years;
- Who hold a Bachelor's degree or above and have an intermediate or above professional title.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Third Affiliated Hospital of Soochow University（THE FIRST PEOPLE'S HOSPITAL OF CHANGZHOU） Coordinator of this site? Confirm its status | Changzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.